View drug registration information details.
Items | Registration information |
ID | 641 |
No | 641 |
Brand Name | VYTOCOR 10 MG/40 MG TABLET |
Ingredients | EZETIMIBE 10 MG, SIMVASTATIN 40 MG |
Dosage Form | TABLET |
Primary Packaging | PVC/PE/PVDC BLISTER |
Storage | STORE BELOW 30 C |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 3 X 10'S |
Dispensing Category | PRESCRIPTION |
ATC Classification | C10BA02 |
Pharmaceutical Class | LIPID MODIFYING AGENT |
Indications | PREVENTION OF CARDIOVASCULAR EVENTS, PRIMARY HYPERCHOLESTEROLEMIA, HOMOZYGOUS FAMILIAL HYPERCHLESTEROLEMIA. |
Contraindications | HYPERSENSITIVITY, ACTIVE LIVER DISEASE, PREGNANCY OR NURSING, |
Side Effects | ALT / AST INCREASED, BLOOD CK INCREASED, MYALGIA, |
Unit Price | |
EDL |
No |
Description | WHITE TO OFF WHITE, 14 MM CAPSULE SHAPED, WITH 40 MARKING ON ONE SIDE AND 10 ON THE OTHER SIDE, UNCOATED TABLET |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | DUOPHARMA MANUFACTURING(BANGI)SDN.BHD. |
Country | MALAYSIA |
Import Registration No | MAL20076021AZ |
Import Registration Date | 2020-07-09 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2022-12-23 |
FDD Registration No | 01 I 5666/24 |
FDD Registration Date | 2024-01-26 |
Expiry Date | 2027-01-25 |
Back to drug list
|